Bloomberg Technology

Moderna Co-Founder Calls Omicron a Major Threat

Moderna co-founder and Flagship Pioneering founder Noubar Afeyan joins Emily Chang to discuss the latest on the Omicron Covid-19 variant, what we know so far, and the process involved in developing a new targeted vaccine.

Published

on

Moderna co-founder and Flagship Pioneering founder Noubar Afeyan joins Emily Chang to discuss the latest on the Omicron Covid-19 variant, what we know so far, and the process involved in developing a new targeted vaccine.

5 Comments

  1. Mikha Rlin

    November 29, 2021 at 11:43 pm

    Of course he would. It’s all about the bottom line

  2. S O

    November 30, 2021 at 12:02 am

    Stop listening to big Pharma and the media, the doctor who discovered the variant has stated that the symptoms were very mild and did not need any hospitalization..

  3. Solomon Oyefeso

    November 30, 2021 at 12:04 am

    He is about to make billions

  4. The Nation of Israel

    November 30, 2021 at 12:34 am

    Pablo Escobar is thrilled that his cocaina is still relevant.

  5. Quiet Jagung

    November 30, 2021 at 12:39 am

    Money, money, money.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version